VAG
BCLI

VisionPoint Advisory Group’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

VisionPoint Advisory Group’s Portfolio BCLI Stock Details BCLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-130
Closed -$658 – 289
2024
Q2 		$658 Hold
130
– – ﹤0.01% 735
2024
Q1 		$1.1K Hold
130
– – ﹤0.01% 721
2023
Q4 		$531 Hold
130
– – ﹤0.01% 684
2023
Q3 		$389 Hold
130
– – ﹤0.01% 638
2023
Q2 		$4.01K Buy
+130
New +$4.01K ﹤0.01% 466